Targeting protein arginine methyltransferase 5 sensitizes glioblastoma to trametinib
Yeshavanth Banasavadi‐Siddegowda(Neurological Surgery), Balveen Kaur(Augusta University), Ji Young Yoo(The University of Texas MD Anderson Cancer Center), Sivarajan Kumarasamy(Ohio University), Yuanqing Yan(Northwestern University), Sarah Rivas(National Institutes of Health), Stuart Walbridge(National Institutes of Health), Yoshihiro Otani(Okayama University), Jean-Paul Bryant(National Institutes of Health), Ashish H. Shah(University of Miami), John D. Heiss(National Institutes of Health), Cole T. Lewis(The University of Texas Health Science Center), Ashis Chowdhury(The University of Texas Health Science Center at Houston), Mitchell Rock(National Institutes of Health), Dragan Maric(National Institute of Neurological Disorders and Stroke), Sriya Namagiri(National Institutes of Health), Allison Shellbourn(National Institutes of Health), Toshihiko Shimizu(The University of Texas Health Science Center), Tae Jin Lee(Augusta University), Sangamesh G. Kumbar(University of Connecticut), Hannah Sur(National Institutes of Health)
Cited by 13
Related Papers
Near real-time intraoperative brain tumor diagnosis using stimulated Raman histology and deep neural networks
|Nature Medicine|2020|768
Microvascular Injury in the Brains of Patients with Covid-19
|New England Journal of Medicine|2020|603
Layer-specific variation of iron content in cerebral cortex as a source of MRI contrast
|Proceedings of the National Academy of Sciences|2010|433
PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic Chemotherapy
|Cell stem cell|2018|423